Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie (Q47685389)
scientific article published on August 1, 1998
Language:
(P31) (Q13442814)
(P50) (Q56548743)
(P304) 2728-2732
(P407) (Q1860)
(P433) 8
(P478) 16
(P577) Saturday, August 1, 1998
Saturday, August 1, 1998
(P921) (Q42824440)
(Q194908)
(Q6934595)
(Q1164529)
(Q19000948)
(Q238512)
(P953) http://intl.jco.org/cgi/content/abstract/16/8/2728
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.1998.16.8.2728
(P1433) (Q400292)
(P1476) "Subcutaneous interleukin-2, interferon alfa-2a, and continuous infusion of fluorouracil in metastatic renal cell carcinoma: a multicenter phase II trial. Groupe Français d'Immunothérapie" (language: en)
(P2093) B. Audhuy
F. Gomez
B. Escudier
T. Lesimple
C. Chevreau
J. Y. Douillard
A. Caty
L. Geoffrois
J. M. Ferrero
C. Linassier
M. Drevon
S. Négrier
other details
description scientific article published on August 1, 1998

External Links